Early astrocyte redistribution in the optic nerve precedes axonopathy in the DBA/2J mouse model of glaucoma

Experimental Eye Research

Volumn 150, Issue , 2016, Pages 22-33

  Cooper, Melissa L ^a   Crish, Samuel D ^b   Inman, Denise M ^b   Horner, Philip J ^c   Calkins, David J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c Biotherapeutics Regenerative Medicine Research Center   (United States)

Author keywords

Astrocyte; Axonopathy; Glaucoma; Gliosis; Neurodegeneration; Retinal ganglion cell

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AXOPLASM; CELL DENSITY; CELL EXPANSION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DBA 2 MOUSE; EXPERIMENTAL GLAUCOMA; INTRAOCULAR PRESSURE; MITOCHONDRION; MOUSE; MYELIN SHEATH; NERVE ELONGATION; NERVE FIBER DEGENERATION; NEUROFILAMENT; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; ANIMAL; AXON; DBA MOUSE; DISEASE MODEL; MICROPHOTOGRAPHY; NERVE DEGENERATION; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASES; PATHOLOGY; RETINA GANGLION CELL; THREE DIMENSIONAL IMAGING; TIME FACTOR;

ANIMALS; ASTROCYTES; AXONS; DISEASE MODELS, ANIMAL; GLAUCOMA, OPEN-ANGLE; IMAGING, THREE-DIMENSIONAL; MICE; MICE, INBRED DBA; NERVE DEGENERATION; OPTIC NERVE; OPTIC NERVE DISEASES; PHOTOMICROGRAPHY; RETINAL GANGLION CELLS; TIME FACTORS;

EID: 84953329691     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.11.016     Document Type: Article

References (50)

1. Anderson, M.G., Smith, R.S., Hawes, N.L., Zabaleta, A., Chang, B., Wiggs, J.L., John, S.W., Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat. Genet. 30 (2002), 81–85.
2. Baltan, S., Inman, D.M., Danilov, C.A., Morrison, R.S., Calkins, D.J., Horner, P.J., Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration. J. Neurosci. 30 (2010), 5644–5652.
3. Bosco, A., Inman, D.M., Steele, M.R., Wu, G., Soto, I., Marsh-Armstrong, N., Hubbard, W.C., Calkins, D.J., Horner, P.J., Vetter, M.L., Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma. Investig. Ophthalmol. Vis. Sci. 49 (2008), 1437–1446.
4. Buckingham, B.P., Inman, D.M., Lambert, W., Oglesby, E., Calkins, D.J., Steele, M.R., Vetter, M.L., Marsh-Armstrong, N., Horner, P.J., Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 28 (2008), 2735–2744.
5. Burgoyne, C.F., A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucoma. Ex. Eye Res. 93 (2011), 120–132.
6. Calkins, D.J., Horner, P.J., Roberts, R., Gradianu, M., Berkowitz, B.A., Manganese-enhanced MRI of the DBA/2J mouse model of hereditary glaucoma. Investig. Ophthalmol. Vis. Sci. 49 (2008), 5083–5088.
7. Calkins, D.J., Critical pathogenic events underlying progression of neurodegeneration in glaucoma. Prog. Retin Eye Res. 31 (2012), 702–719.
8. Calkins, D.J., Age-related changes in the visual pathways: blame it on the axon. Investig. Ophthalmol. Vis. Sci., 54, 2013 ORSF37–41.
9. Castellano, B., González, B., Jensen, M.B., Pedersen, E.B., Finsen, B.R., Zimmer, J., A double staining technique for simultaneous demonstration of astrocytes and microglia in brain sections and astroglial cell cultures. J. Histochem Cytochem 39 (1991), 561–568.
10. Chang, B., Smith, R.S., Hawes, N.L., Anderson, M.G., Zabaleta, A., Savinova, O., Roderick, T.H., Heckenlively, J.R., Davisson, M.T., John, S.W., Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat. Genet. 21 (1999), 405–409.
11. Coughlin, L., Morrison, R.S., Horner, P.J., Inman, D.M., Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve. Investig. Ophthalmol. Vis. Sci. 56 (2015), 1437–1446.
12. Crish, S.D., Sappington, R.M., Inman, D.M., Horner, P.J., Calkins, D.J., Distal axonopathy with structural persistence in glaucomatous neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 5196–5201.
13. Crish, S.D., Dapper, J.D., MacNamee, S.E., Balaram, P., Sidorova, T.N., Lambert, W.S., Calkins, D.J., Failure of axonal transport induces a spatially coincident increase in astrocyte BDNF prior to synapse loss in a central target. Neuroscience 229 (2013), 55–70.
14. Danias, J., Lee, K.C., Zamora, M.F., Chen, B., Shen, F., Filippopoulos, T., Su, Y., Goldblum, D., Podos, S.M., Mittag, T., Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Investig. Ophthalmol. Vis. Sci. 44 (2003), 5151–5162.
15. Dai, C., Khaw, P.T., Yin, Z.Q., Li, D., Raisman, G., Li, Y., Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure. Glia 60 (2012), 13–28.
16. Fitzgerald, M., Bartlett, C.A., Harvey, A.R., Dunlop, S.A., Early events of secondary degeneration after partial optic nerve transection: an immunohistochemical study. J. Neurotrauma 27 (2010), 439–452.
17. Goldstein, M.E., Cooper, H.S., Bruce, J., Carden, M.J., Lee, V.M., Schlaepfer, W.W., Phosphorylation of neurofilament proteins and chromatolysis following transection of rat sciatic nerve. J. Neurosci. 7 (1987), 1586–1594.
18. Gordon, M.O., Beiser, J.A., Brandt, J.D., Heuer, D.K., Higginbotham, E.J., Johnson, C.A., Keltner, J.L., Miller, J.P., Parrish, R.K. 2nd, Wilson, M.R., Kass, M.A., The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120 (2002), 714–720.
19. Hernandez, M.R., The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog. Retin Eye Res. 19 (2000), 297–321.
20. Howell, G.R., Libby, R.T., Marchant, J.K., Wilson, L.A., Cosma, I.M., Smith, R.S., Anderson, M.G., John, S., Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1. BMC Genet., 8, 2007, 45.
21. Howell, G.R., Libby, R.T., Jakobs, T.C., Smith, R.S., Phalan, F.C., Barter, J.W., Barbay, J.M., Marchant, J.K., Mahesh, N., Porciatti, V., Whitmore, A.V., Masland, R.H., John, S.W., Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J. Cell Biol. 179 (2007), 1523–1537.
22. Inman, D.M., Sappington, R.M., Horner, P.J., Calkins, D.J., Quantitative correlation of optic nerve pathology with ocular pressure and corneal thickness in the DBA/2J mouse model of glaucoma. Investig. Ophthalmol. Vis. Sci. 47 (2006), 986–996.
23. Jakobs, T.C., Libby, R.T., Ben, Y., John, S.W., Masland, R.H., Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J. Cell Biol. 171 (2005), 313–325.
24. John, S.W., Smith, R.S., Savinova, O.V., Hawes, N.L., Chang, B., Turnbull, D., Davisson, M., Roderick, T.H., Heckenlively, J.R., Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Investig. Ophthalmol. Vis. Sci. 39 (1998), 951–962.
25. Johnson, E.C., Deppmeier, L.M., Wentzien, S.K., Hsu, I., Morrison, J.C., Chronology of optic nerve head and retinal responses to elevated intraocular pressure. Investig. Ophthalmol. Vis. Sci. 41 (2000), 431–442.
26. Leske, M.C., Heijl, A., Hussein, M., Bengtsson, B., Hyman, L., Komaroff, E., Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch. Ophthalmol. 121 (2003), 48–56.
27. Li, Y., Li, D., Ying, X., Khaw, P.T., Raisman, G., An energy theory of glaucoma. Glia 63 (2015), 1537–1552.
28. Libby, R.T., Anderson, M.G., Pang, I.H., Robinson, Z.H., Savinova, O.V., Cosma, I.M., Snow, A., Wilson, L.A., Smith, R.S., Clark, A.F., John, S.W., Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis. Neurosci. 22 (2005), 637–648.
29. Nickells, R.W., From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can. J. Ophthalmol. 42 (2007), 278–287.
30. Payne, S.C., Barlett, C.A., Harvey, A.R., Dunlop, S.A., Fitzgerald, M., Myelin sheath decompaction, axon swelling, and functional loss during chronic secondary degeneration in rat optic nerve. Investig. Ophthalmol. Vis. Sci. 53 (2012), 6093–6101.
31. Perge, J.A., Koch, K., Miller, R., Sterling, P., Balasubramanian, V., How the optic nerve allocates space, energy capacity, and information. J. Neurosci. 29 (2009), 7917–7928.
32. Povlishock, J.T., Becker, D.P., Fate of reactive axonal swellings induced by head injury. Lab. Investig. 52 (1985), 540–552.
33. Quigley, H.A., Neuronal death in glaucoma. Prog. Retin Eye Res. 18 (1999), 39–57.
34. Quigley, H.A., Flower, R.W., Addicks, E.M., McLeod, D.S., The mechanism of optic nerve damage in experimental acute intraocular pressure elevation. Investig. Ophthalmol. Vis. Sci. 19 (1980), 505–517.
35. Saleh, M., Nagaraju, M., Porciatti, V., Longitudinal evaluation of retinal ganglion cell function and IOP in the DBA/2 mouse model of glaucoma. Investig. Ophthalmol. Vis. Sci. 48 (2007), 4564–4572.
36. Sappington, R.M., Pearce, D.A., Calkins, D.J., Optic nerve degeneration in a murine model of juvenile ceroid lipofuscinosis. Investig. Ophthalmol. Vis. Sci. 44 (2003), 3725–3731.
37. Schlamp, C.L., Li, Y., Dietz, J.A., Janssen, K.T., Nickells, R.W., Progressive ganglion cell loss and optic nerve degeneration in DBA/2 mice is variable and asymmetric. BMC Neurosci., 7, 2006, 66.
38. Scholz, M., Buder, T., Seeber, S., Adamek, E., Becker, C.M., Lütjen-Drecoll, E., Dependency of intraocular pressure elevation and glaucomatous changes in DBA/2J and DBA/2J-Rj mice. Investig. Ophthalmol. Vis. Sci. 49 (2008), 613–621.
39. Schuettauf, F., Rejdak, R., Walski, M., Frontczak-Baniewicz, M., Voelker, M., Blatsios, G., Shinoda, K., Zagorski, Z., Zrenner, E., Grieb, P., Retinal neurodegeneration in the DBA/2J mouse-a model for ocular hypertension. Acta Neuropathol. 107 (2004), 352–358.
40. Shea, T.B., Chan, W.K., Regulation of neurofilament dynamics by phosphorylation. Eur. J. Neurosci. 27 (2008), 1893–1901.
41. Sheldon, W.G., Warbritton, A.R., Bucci, T.J., Turturro, A., Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab. Anim. Sci. 45 (1995), 508–518.
42. Soto, I., Oglesby, E., Buckingham, B.P., Son, J.L., Roberson, E.D., Steele, M.R., Inman, D.M., Vetter, M.L., Horner, P.J., Marsh-Armstrong, N., Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model. J. Neurosci. 28 (2008), 548–561.
43. Sternberger, L.A., Harwell, L.W., Sternberger, N.H., Neurotypy: regional individuality in rat brain detected by immunocytochemistry with monoclonal antibodies. Proc. Natl. Acad. Sci. U. S. A. 79 (1982), 1326–1330.
44. Sternberger, L.A., Sternberger, N.H., Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. Proc. Natl. Acad. Sci. U. S. A. 80 (1983), 6126–6130.
45. Sun, D., Jakobs, T.C., Structural remodeling of astrocytes in the injured CNS. Neuroscientist 18 (2012), 567–588.
46. Sun, D., Qu, J., Jakobs, T.C., Reversible reactivity by optic nerve astrocytes. Glia 61 (2013), 1218–1235.
47. Tuck, M.W., Crick, R.P., The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol. 5 (1998), 173–183.
48. Williams, R.W., Strom, R.C., Rice, D.S., Goldowitz, D., Genetic and environmental control of variation in retinal ganglion cell number in mice. J. Neurosci. 16 (1996), 7193–7205.
49. Whitmore, A.V., Libby, R.T., John, S.W., Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes?. Prog. Retin Eye Res. 24 (2005), 639–662.
50. Zhou, X., Li, F., Kong, L., Tomita, H., Li, C., Cao, W., Involvement of inflammation, degradation, and apoptosis in a mouse model of glaucoma. J. Biol. Chem. 280 (2005), 31240–31248.